Lanreotide - Ipsen
At a glance
- Drug Originator Northwell Health; Tulane University
- Drug Licenced by EMD Serono; Ipsen; Ipsen Biopharmaceuticals; Menarini Asia-Pacific; Teijin Pharma
- Drug Class Antineoplastics; Cyclic peptides; Eye disorder therapies; Pancreatic hormones; Pituitary hormone release inhibiting hormones; Urologics; Vascular disorder therapies
- Mechanism of Action Growth hormone-releasing hormone inhibitors
- USA Patent Applicants IPSEN PHARMA
- USA Patents 1
- NDAs 1
- Patent Applications 2,197
Table of Contents

Disclaimer